CCMP to reduce Jamieson stake in $150 mln secondary sale
U.S. private equity firm CCMP Capital Advisors has agreed to sell additional common shares of Jamieson Wellness Inc (TSX: JWEL), a Canadian vitamin maker that went public in July. CCMP will sell 8.1 million shares for 18.50 per unit. Together with a concurrent secondary sale, the gross proceeds will be about $150.2 million, not including the offering's greenshoe option. CCMP, which acquired Jamieson in 2014, will as a result reduce its stake from 39.2 percent to 17.7 percent, or 14.4 percent if the greenshoe option is exercised in full. As reported by PE Hub Canada, CCMP earned 3x its invested capital from Jamieson's initial public offering.
2 October 2017•4 mins read
